CryoPort (NASDAQ:CYRX) Insider Edward Zecchini Sells 2,014 Shares

March 18, 2026 by InsiderTrades.com

Key Points

CryoPort CEO Jerrell Shelton sold 7,918 shares on Mar 16 at $8.00, trimming his stake by about 0.75% (SEC filing), and his sale was accompanied by larger insider dispositions from the CFO and other executives that may weigh on sentiment.
Q4 results were mixed: revenue beat estimates at $45.45M vs. $42.92M, but EPS missed at ($0.21) vs. ($0.19); the stock trades around $8 with a market cap of roughly $417M and a 52‑week range of $4.63–$11.45.
Analyst and ownership backdrop is mixed — eight Buys, one Hold and one Sell give a MarketBeat consensus of "Moderate Buy" with an average target of $12.94, while institutional ownership is high (~92.9%), concentrating shares.

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) insider Edward Zecchini sold 2,014 shares of the company's stock in a transaction on Monday, March 16th. The shares were sold at an average price of $8.00, for a total transaction of $16,112.00. Following the completion of the sale, the insider directly owned 109,719 shares in the company, valued at approximately $877,752. This represents a 1.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

CryoPort Price Performance

Shares of NASDAQ:CYRX opened at $8.36 on Wednesday. CryoPort, Inc. has a 1 year low of $4.63 and a 1 year high of $11.45. The business's 50-day moving average is $9.19 and its 200-day moving average is $9.36. The company has a market capitalization of $416.83 million, a price-to-earnings ratio of 6.33 and a beta of 1.69.

CryoPort (NASDAQ:CYRX - Get Free Report) last posted its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.21) EPS for the quarter, missing analysts' consensus estimates of ($0.19) by ($0.02). The company had revenue of $45.45 million during the quarter, compared to analyst estimates of $42.92 million. CryoPort had a negative return on equity of 8.22% and a net margin of 42.35%. Analysts anticipate that CryoPort, Inc. will post -0.99 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on CYRX shares. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of CryoPort in a report on Monday, December 29th. Wall Street Zen lowered shares of CryoPort from a "hold" rating to a "sell" rating in a research report on Saturday, March 7th. Finally, Needham & Company LLC boosted their price target on shares of CryoPort from $12.00 to $13.00 and gave the stock a "buy" rating in a report on Wednesday, March 4th. Eight equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, CryoPort presently has a consensus rating of "Moderate Buy" and a consensus price target of $12.94.

Get Our Latest Stock Report on CYRX

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Corient Private Wealth LLC bought a new stake in shares of CryoPort in the fourth quarter valued at approximately $113,000. Invesco Ltd. grew its stake in CryoPort by 19.3% in the 4th quarter. Invesco Ltd. now owns 96,541 shares of the company's stock valued at $927,000 after buying an additional 15,607 shares in the last quarter. XTX Topco Ltd bought a new stake in CryoPort during the 4th quarter valued at $424,000. Tudor Investment Corp ET AL raised its holdings in CryoPort by 3.3% during the 4th quarter. Tudor Investment Corp ET AL now owns 300,414 shares of the company's stock valued at $2,884,000 after acquiring an additional 9,690 shares during the period. Finally, Quadrature Capital Ltd purchased a new stake in shares of CryoPort during the fourth quarter worth $97,000. Institutional investors own 92.90% of the company's stock.

Key Stories Impacting CryoPort

Here are the key news stories impacting CryoPort this week:

Positive Sentiment: Analyst upgrade/target increase: Needham raised its target to $13 and reiterated a "buy" view, which supports upside expectations and may be helping the stock's strength. MarketBeat CYRX Analyst Coverage
Neutral Sentiment: Mixed Q4 results remain in the backdrop — revenue beat consensus but EPS missed modestly; investors may be parsing near-term profitability versus top-line growth. MarketBeat CYRX Earnings Summary
Neutral Sentiment: Institutional activity: several small/new stakes were reported (various funds adding modest positions); institutional ownership remains high (~93%), which can reduce float volatility but also concentrate moves. MarketBeat CYRX Institutional Ownership
Negative Sentiment: Insider selling — CEO Jerrell Shelton sold 7,918 shares at an average $8.00 on Mar 16 (ownership decreased ~0.75%), a signal some investors view as negative. CEO SEC Filing
Negative Sentiment: Significant CFO selling — Robert Stefanovich disclosed a larger sale on Mar 12 of 38,700 shares (~13.15% of his prior holding) and additional sales on Mar 16 (2,743 shares). Large insider liquidation by a senior finance officer can weigh on sentiment. CFO SEC Filing
Negative Sentiment: Additional insider sales: Mark W. Sawicki sold 3,235 shares and Edward J. Zecchini sold 2,014 shares on Mar 16 — cumulatively these insider dispositions add to negative optics even if dollar amounts are modest. Insider SEC Filings

About CryoPort

(Get Free Report)

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort's product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.